Rankings
▼
Calendar
LSTA FY 2017 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
LSTA
Lisata Therapeutics, Inc.
$44M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$372,000
Operating Income
-$28M
Net Income
$23M
EPS (Diluted)
$38.43
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$21M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$63M
Total Liabilities
$13M
Stockholders' Equity
$51M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$35M
-100.0%
Gross Profit
-$372,000
$4M
-109.0%
Operating Income
-$28M
-$31M
+11.9%
Net Income
$23M
-$33M
+170.4%
← Q4 2016
All Quarters
Q1 2017 →